UA91717C2 - Administration of 2-[[6-[(3r)-3-amino-l-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo- l(2h)-pyrimaidinyl]methyl]-benzonitrile for the treatment of conditions mediated with dipeptidyl peptidase inhibitors - Google Patents

Administration of 2-[[6-[(3r)-3-amino-l-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo- l(2h)-pyrimaidinyl]methyl]-benzonitrile for the treatment of conditions mediated with dipeptidyl peptidase inhibitors

Info

Publication number
UA91717C2
UA91717C2 UAA200804053A UAA200804053A UA91717C2 UA 91717 C2 UA91717 C2 UA 91717C2 UA A200804053 A UAA200804053 A UA A200804053A UA A200804053 A UAA200804053 A UA A200804053A UA 91717 C2 UA91717 C2 UA 91717C2
Authority
UA
Ukraine
Prior art keywords
methyl
pyrimaidinyl
benzonitrile
dioxo
piperidinyl
Prior art date
Application number
UAA200804053A
Other languages
Russian (ru)
Inventor
Роналд Дж. Кристофер
Пол Ковингтон
Original Assignee
Такеда Фармасьютикал Компани Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40125749&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA91717(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Такеда Фармасьютикал Компани Лимитед filed Critical Такеда Фармасьютикал Компани Лимитед
Priority claimed from PCT/US2006/035708 external-priority patent/WO2007033266A2/en
Publication of UA91717C2 publication Critical patent/UA91717C2/en

Links

Abstract

Pharmaceutical compositions comprising 2-[[6-[(3R)-3-amino-l-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo- l(2H)-pyrimaidinyl]methyl]-benzonitrile and pharmaceutically acceptable salts thereof are provided as well as kits and articles of manufacture comprising the pharmaceutical compositions as well as methods of using the pharmaceutical compositions.
UAA200804053A 2005-09-14 2006-09-13 Administration of 2-[[6-[(3r)-3-amino-l-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo- l(2h)-pyrimaidinyl]methyl]-benzonitrile for the treatment of conditions mediated with dipeptidyl peptidase inhibitors UA91717C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71755805P 2005-09-14 2005-09-14
PCT/US2006/035708 WO2007033266A2 (en) 2005-09-14 2006-09-13 Dipeptidyl peptidase inhibitors for treating diabetis

Publications (1)

Publication Number Publication Date
UA91717C2 true UA91717C2 (en) 2010-08-25

Family

ID=40125749

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200804053A UA91717C2 (en) 2005-09-14 2006-09-13 Administration of 2-[[6-[(3r)-3-amino-l-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo- l(2h)-pyrimaidinyl]methyl]-benzonitrile for the treatment of conditions mediated with dipeptidyl peptidase inhibitors

Country Status (4)

Country Link
AR (1) AR108699A2 (en)
JO (1) JO3721B1 (en)
UA (1) UA91717C2 (en)
ZA (1) ZA200802855B (en)

Also Published As

Publication number Publication date
ZA200802855B (en) 2009-11-25
JO3721B1 (en) 2021-01-31
AR108699A2 (en) 2018-09-19

Similar Documents

Publication Publication Date Title
MY159522A (en) Administration of dipeptidyl peptidase inhibitors
MX2009002772A (en) Administration of dipeptidyl peptidase inhibitors.
TW200744602A (en) Administration of dipeptidyl peptidase inhibitors
UA101313C2 (en) Normal;heading 1;heading 2;heading 3;WEEKLY ADMINISTRATION OF DIPEPTIDYL PEPTIDASE INHIBITORS
MX2008011633A (en) Aminoquinolones as gsk-3 inhibitors.
WO2006004636A3 (en) Fused heterocyclic kinase inhibitors
TW200833693A (en) Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
MX2009006345A (en) Compounds useful as protein kinase inhibitors.
MX2009008253A (en) Kinase inhibitors.
MX2009006690A (en) Aminopyrimidines useful as inhibitors of protein kinases.
WO2008112651A3 (en) Aminopyrimidines useful as inhibitors of protein kinases
MX2009009592A (en) Aminopyridines useful as inhibitors of protein kinases.
HK1162502A1 (en) Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors gsk-3
IL205696A0 (en) Heterocyclic derivatives, compositions comprising the same and uses thereof
MX2009005231A (en) Compounds useful as protein kinase inhibitors.
UA102219C2 (en) Substotuted pyrazolo-quinazoline derivatives, process for the preparation and use thereof as kinase inhibitors
UA91717C2 (en) Administration of 2-[[6-[(3r)-3-amino-l-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo- l(2h)-pyrimaidinyl]methyl]-benzonitrile for the treatment of conditions mediated with dipeptidyl peptidase inhibitors
IL181666A0 (en) Indolin-2-one pyridine derivatives, preparation and therapeutic use thereof
UA93689C2 (en) Administration of dipeptidyl peptidase inhibitors
UA99112C2 (en) Use of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydr0-2h-pyrimidin-1-ylmethyl]-4-fluorobenzonitrile